Intestinal mucosal barrier function in health and disease
暂无分享,去创建一个
[1] M. Osterman. IFN-γ-Induced TNFR2 Expression Is Required for TNF-Dependent Intestinal Epithelial Barrier DysfunctionWang F, Schwarz BT, Graham WV, et al (Third Military Med Univ, Chongqing, China; Univ of Chicago) Gastroenterology 131:1153–1163, 2006§ , 2007 .
[2] M. Marinaro,et al. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis. , 2008, Gastroenterology.
[3] Michael M. Wang,et al. Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial Cells* , 2009, The Journal of Biological Chemistry.
[4] W. V. Graham,et al. Interferon-γ and Tumor Necrosis Factor-α Synergize to Induce Intestinal Epithelial Barrier Dysfunction by Up-Regulating Myosin Light Chain Kinase Expression , 2005 .
[5] M. Zeitz,et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. , 2005, Gastroenterology.
[6] M. Netea,et al. A Crohn's disease–associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1 , 2009, Nature Immunology.
[7] E. Dejana,et al. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. , 2008, Gastroenterology.
[8] Yasuo Tano,et al. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. , 2002, Journal of the American Society of Nephrology : JASN.
[9] E. Severson,et al. JAM-A regulates permeability and inflammation in the intestine in vivo , 2007, The Journal of experimental medicine.
[10] J. Meddings,et al. Intestinal glucose transport using perfused rat jejunum in vivo: model analysis and derivation of corrected kinetic constants. , 1989, Clinical science.
[11] Y. Belkaid,et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism , 2007, The Journal of experimental medicine.
[12] P. Verkade,et al. Clostridium difficile Toxins Disrupt Epithelial Barrier Function by Altering Membrane Microdomain Localization of Tight Junction Proteins , 2001, Infection and Immunity.
[13] J. Genschel,et al. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? , 2005, Gut.
[14] Le Shen,et al. Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. , 2005, Molecular biology of the cell.
[15] Lena Holm,et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria , 2010, Gut microbes.
[16] C. V. Van Itallie,et al. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2 , 2008, Journal of Cell Science.
[17] A. Sjöqvist,et al. Permeability of the rat small intestinal epithelium along the villus-crypt axis: effects of glucose transport. , 2000, Gastroenterology.
[18] K. Madsen,et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. , 1999, Inflammatory bowel diseases.
[19] S. Lees-Miller,et al. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. , 2002, Gastroenterology.
[20] D. Rubin,et al. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation , 2008, Laboratory Investigation.
[21] O. Baker,et al. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line. , 2008, American Journal of Physiology - Cell Physiology.
[22] Hidde L Ploegh,et al. CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.
[23] R Balfour Sartor,et al. Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.
[24] H. Lochs,et al. Intestinal permeability and the prediction of relapse in Crohri's disease , 1993, The Lancet.
[25] Hilde Cheroutre,et al. Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.
[26] P. Rutgeerts,et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease , 2002, American Journal of Gastroenterology.
[27] T. Sakaguchi,et al. Claudins regulate the intestinal barrier in response to immune mediators. , 2000, Gastroenterology.
[28] Tomohiro Watanabe,et al. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. , 2008, The Journal of clinical investigation.
[29] R. Ricketts. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in crohn's ileocolitis: F.J. Baert, G.R. D'Haens, M. Peelers, et al. Gastroenterology 116:22–28 (January), 1999 , 2000 .
[30] Kozo Kaibuchi,et al. Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.
[31] Jun Hee Lee,et al. Energy-dependent regulation of cell structure by AMP-activated protein kinase , 2007, Nature.
[32] A. Pedram,et al. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[33] K. Kurokawa,et al. Effect of phosphorylation of myosin light chain by myosin light chain kinase and protein kinase C on conformational change and ATPase activities of human platelet myosin. , 1991, Blood.
[34] D. Balkovetz,et al. Downregulation of claudin-2 expression in renal epithelial cells by metabolic acidosis. , 2009, American journal of physiology. Renal physiology.
[35] K. Madsen,et al. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse , 2008, Gut.
[36] A. Ridley,et al. Roles of Rho/ROCK and MLCK in TNF‐α‐induced changes in endothelial morphology and permeability , 2007, Journal of cellular physiology.
[37] T. Noda,et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. , 2000, Molecular biology of the cell.
[38] C. Bertrand,et al. LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK , 2005, European Respiratory Journal.
[39] K. Madsen,et al. The role of antibiotic and probiotic therapies in current and future management of inflammatory Bowel disease , 2006, Current gastroenterology reports.
[40] E. Cario,et al. Barrier-protective function of intestinal epithelial Toll-like receptor 2 , 2008, Mucosal Immunology.
[41] J. Rotter,et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. , 1986, Annals of internal medicine.
[42] M. Montrose,et al. Regulated alkali secretion acts in tandem with unstirred layers to regulate mouse gastric surface pH. , 2004, Gastroenterology.
[43] A. Prince,et al. TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. , 2009, Cell host & microbe.
[44] A. Craft,et al. Intestinal permeability in children with Crohn's disease and coeliac disease. , 1982, British medical journal.
[45] Sarah L. Brown,et al. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. , 2007, The Journal of clinical investigation.
[46] K. Barrett,et al. Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[47] J. Madara,et al. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. , 1989, The Journal of clinical investigation.
[48] M. Washington,et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. , 2005, The Journal of clinical investigation.
[49] J. Turner,et al. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease , 2006, Laboratory Investigation.
[50] W. Lencer,et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure , 2006, Journal of Cell Science.
[51] F. Powrie,et al. Dendritic cells in intestinal immune regulation , 2008, Nature Reviews Immunology.
[52] L. Zeef,et al. Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(−/−) mice , 2008, Inflammatory bowel diseases.
[53] J. Turner,et al. Regulation of human jejunal transmucosal resistance and MLC phosphorylation by Na(+)-glucose cotransport. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[54] D. Duerksen,et al. Intestinal Permeability in Long-Term Follow-up of Patients with Celiac Disease on a Gluten-Free Diet , 2005, Digestive Diseases and Sciences.
[55] J. Marshall,et al. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. , 2000, Gastroenterology.
[56] L. M. Russo,et al. Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability. , 1992, The American journal of physiology.
[57] E. Chang,et al. Akt2 Phosphorylates Ezrin to Trigger NHE3 Translocation and Activation* , 2005, Journal of Biological Chemistry.
[58] R. Peek,et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. , 2009, Gastroenterology.
[59] A. Hopkins,et al. Interferon‐γ induces internalization of epithelial tight junction proteins via a macropinocytosis‐like process , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] J. Lebreton,et al. Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. , 1997, The American journal of physiology.
[61] M. Rescigno,et al. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning , 2009, Mucosal Immunology.
[62] A. Malik,et al. Synergistic effects of tumor necrosis factor-alpha and thrombin in increasing endothelial permeability. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[63] J. Pilewski,et al. Role of CFTR in airway disease. , 1999, Physiological reviews.
[64] G. Corazza,et al. Measurements of the jejunal unstirred layer in normal subjects and patients with celiac disease. , 1996, The American journal of physiology.
[65] Jason X. Cheng,et al. Tumor Necrosis Factor-induced Long Myosin Light Chain Kinase Transcription Is Regulated by Differentiation-dependent Signaling Events , 2006, Journal of Biological Chemistry.
[66] C. Goodnow,et al. Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis , 2008, PLoS medicine.
[67] J. Nougayrède,et al. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. , 2001, The Journal of clinical investigation.
[68] R. Mrsny,et al. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. , 2002, Gastroenterology.
[69] D. Artis. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut , 2008, Nature Reviews Immunology.
[70] M. H. Cheng,et al. Molecular Basis for Cation Selectivity in Claudin-2–based Paracellular Pores: Identification of an Electrostatic Interaction Site , 2009, The Journal of general physiology.
[71] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[72] J. Frank,et al. Claudin-4 augments alveolar epithelial barrier function and is induced in acute lung injury. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[73] D. Sachar,et al. Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. , 1968, The New England journal of medicine.
[74] J. Meijerink,et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.
[75] C. V. Van Itallie,et al. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. , 2003, American journal of physiology. Cell physiology.
[76] J. Gordon,et al. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death , 1995, The Journal of cell biology.
[77] yang-xin fu,et al. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. , 2007, Gastroenterology.
[78] W. Nelson,et al. Structural and Functional Regulation of Tight Junctions by RhoA and Rac1 Small GTPases , 1998, The Journal of cell biology.
[79] V. Théodorou,et al. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. , 2005, The American journal of pathology.
[80] S. Targan,et al. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. , 1997, Journal of immunology.
[81] R. Sartor,et al. Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. , 2001, Gastroenterology.
[82] R. Mrsny,et al. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. , 1997, The American journal of physiology.
[83] Liping Su,et al. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. , 2009, Gastroenterology.
[84] E. Mazzon,et al. Role of TNF-α in lung tight junction alteration in mouse model of acute lung inflammation , 2007, Respiratory research.
[85] B. Beutler,et al. Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. , 1999, Gastroenterology.
[86] R. Mrsny,et al. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. , 2005, The Journal of clinical investigation.
[87] R. Lifton,et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. , 1999, Science.
[88] R. Mrsny,et al. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. , 2005, Molecular biology of the cell.
[89] U Wahnschaffe,et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease , 2006, Gut.
[90] G. Warhurst,et al. Interferon-γ selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores , 2005, Journal of Cell Science.
[91] L. Mayer,et al. Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease , 2006, Inflammatory bowel diseases.
[92] K. Czymmek,et al. Deletion of JAM-A causes morphological defects in the corneal epithelium. , 2007, The international journal of biochemistry & cell biology.
[93] A. Andoh,et al. Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.
[94] Klaus Ley,et al. The primary defect in experimental ileitis originates from a nonhematopoietic source , 2006, The Journal of experimental medicine.
[95] R. Coffman,et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. , 1994, Immunity.
[96] C. Chabo,et al. Gastrointestinal , Hepatobiliary and Pancreatic Pathology Impairment of the Intestinal Barrier by Ethanol Involves Enteric Microflora and Mast Cell Activation in Rodents , 2006 .
[97] M. Leitges,et al. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. , 2006, The Journal of clinical investigation.
[98] G. Dalmasso,et al. Temporal and Spatial Analysis of Clinical and Molecular Parameters in Dextran Sodium Sulfate Induced Colitis , 2009, PloS one.
[99] A. Amiot,et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. , 2009, Gastroenterology.
[100] Yoshiharu Matsuura,et al. Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)* , 1996, The Journal of Biological Chemistry.
[101] D. Ye,et al. Mechanism of IL-1β-Induced Increase in Intestinal Epithelial Tight Junction Permeability1 , 2008, The Journal of Immunology.
[102] R. Germain,et al. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement , 2006, The Journal of experimental medicine.
[103] K. Barrett,et al. AMP-activated Protein Kinase Mediates the Interferon-γ-induced Decrease in Intestinal Epithelial Barrier Function* , 2009, The Journal of Biological Chemistry.
[104] J. Gordon,et al. Inflammatory Bowel Disease and Adenomas in Mice Expressing a Dominant Negative N-Cadherin , 1995, Science.
[105] O. Benada,et al. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells , 2007, Inflammatory bowel diseases.
[106] R. Xu,et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. , 2006, Gastroenterology.
[107] Xiao-pei Gao,et al. Nonmuscle myosin light-chain kinase mediates neutrophil transmigration in sepsis-induced lung inflammation by activating β2 integrins , 2008, Nature Immunology.
[108] D. Hollander,et al. Crohn's disease--a permeability disorder of the tight junction? , 1988, Gut.
[109] A. Yu,et al. Structure-Function Studies of Claudin Extracellular Domains by Cysteine-scanning Mutagenesis* , 2009, The Journal of Biological Chemistry.
[110] P. Kozlowski,et al. Mucosal vaccines: the promise and the challenge , 2006, Nature Reviews Immunology.
[111] J. Pappenheimer,et al. Structural basis for physiological regulation of paracellular pathways in intestinal epithelia , 2005, The Journal of Membrane Biology.
[112] C. V. Van Itallie,et al. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. , 2009, Molecular biology of the cell.
[113] Torsten Schöneberg,et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells , 2002, Journal of Cell Science.
[114] H. Tilg,et al. XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease , 2008, Cell.
[115] Tomohiro Watanabe,et al. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. , 2007, Gastroenterology.
[116] Alastair Forbes,et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease , 2008, Nature Genetics.
[117] Judy H. Cho,et al. Chronic stimulation of Nod2 mediates tolerance to bacterial products , 2007, Proceedings of the National Academy of Sciences.
[118] S. Colgan,et al. Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. , 1998, Gastroenterology.